DocCheck AG is a Germany-based Company. The Company is engaged in the healthcare sector. The are three main business areas: agency business, access business and retail business. The agency business develops and implements communication concepts for the healthcare and B2B market. The access business helps to grow community for medical professionals. It also includes online advertising, online market research, online studies. The retail business provides medical supplies and medical technology.

Employees

Sector

Healthcare Facilities & Services

More about the company

Market Cap	61.39M 70.25M 56.75M 52.43M 98.74M 6.75B 101M 677M 266M 3.3B 264M 258M 11.38B	P/E 2024	8.03x	P/E 2025	11.7x
Enterprise Value	43.8M 50.12M 40.49M 37.41M 70.45M 4.81B 71.73M 483M 189M 2.36B 188M 184M 8.12B	EV / Sales 2024	0.41x	EV / Sales 2025	0.81x
Free-Float	28.08%	Yield 2024	8.98%	Yield 2025	8.13%

04-16	DocCheck AG announces Annual dividend, payable on June 02, 2026	CI
04-08	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2025	CI
25-09-29	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2025	CI
25-04-15	DocCheck AG announces Annual dividend, payable on June 02, 2025	CI
25-04-09	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2024	CI
24-09-23	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2024	CI
24-04-11	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2023	CI
23-09-30	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2023	CI
23-04-13	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2022	CI
22-07-29	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2022	CI
22-04-14	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2021	CI
21-10-28	DocCheck AG Reports Earnings Results for the Half Year Ended June 30, 2021	CI
21-04-15	DocCheck AG Reports Earnings Results for the Full Year Ended December 31, 2020	CI

04-16	DocCheck : Information pursuant to Section 125 para. 2 German Stock Corporation Act (AktG) in connection with Section 125 para. 5 AktG, Article 4 para. 1 and Table 3 of the Annex to Implementing Regulation (EU) 2018/1212 (DocCheck Informationen nach 125 AktG und Tabelle 3 Blocke A bis F Durchfuhrungsverordnung EU 2018 1212 engl)	PU
25-04-15	DocCheck : Information pursuant to Section 125 para. 2 German Stock Corporation Act (AktG) in connection with Section 125 para. 5 AktG, Article 4 para. 1 and Table 3 of the Annex to Implementing Regulation (EU) 2018/1212 (2025 DocCheck Informationen nach 125 AktG englisch und Tabelle 3 Bloecke A to F)	PU
23-05-04	DD: DocCheck AG: Dr. Frank Antwerpes, buy	EQ
20-03-05	DocCheck AG : Notification and public disclosure of transactions by persons	EQ

05-28	DocCheck : Abstimmungsergebnisse (AJ91 Abstimmungsergebnisse HV2026)
05-28	DocCheck : Nachtrag (AJ91 1 Nachtrag)
05-25	Kalender der Dividendenausschüttungen und Hauptversammlungen vom 25. bis 29. Mai 2026
05-20	Vorläufige Zahlen zum ersten Quartal 2026
05-07	DocCheck : Jahresabschluss für das Geschäftsjahr 2025 und Lagebericht (DocCheck AG Einzelabschluss 31.12.2025 2)

Manager	Title	Age	Since
Frank Nicolas Antwerpes CEO	Chief Executive Officer	65	-
Philip Stadtmann DFI	Director of Finance/CFO	-	2019-07-31
Jens Knoop CTO	Chief Tech/Sci/R&D Officer	-	2019-07-31

DocCheck AG Stock BOERSE BERLIN

Stocks

ANWGn

DE000A1A6WE6

Healthcare Facilities & Services

Valuation: DocCheck AG

Latest news : DocCheck AG

Press Releases: DocCheck AG

News in other languages: DocCheck AG

Managers and Directors: DocCheck AG

Other Healthcare Facilities & Services

Financials

Company Profile

Director	Title	Age	Since
Joachim Pietzko CHM	Chairman	-	2014-12-14
Winfried Leimeister BRD	Director/Board Member	-	1998-12-31
Karin Immenroth BRD	Director/Board Member	-	2022-03-30

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
DOCCHECK AG	-.--%	-.--%	-	-	70M
CVS HEALTH CORPORATION	+0.26%	+1.77%	+64.98%	+48.75%	135B
HCA HEALTHCARE, INC.	-6.95%	-14.06%	-4.43%	+22.61%	86.68B
FRESENIUS SE & CO. KGAA	-1.61%	-5.51%	-2.29%	+57.10%	26.77B
QUEST DIAGNOSTICS INCORPORATED	-0.65%	-3.00%	+22.35%	+46.68%	22.95B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY	-0.46%	-1.06%	-18.43%	-27.14%	20.06B
TENET HEALTHCARE CORPORATION	-5.71%	-12.03%	+3.35%	+124.29%	16.78B
REDE D'OR SÃO LUIZ S.A.	+1.38%	+3.50%	+7.81%	+12.80%	15.25B
DAVITA INC.	-1.35%	-0.81%	+62.06%	+124.03%	15.12B
FRESENIUS MEDICAL CARE AG	-1.26%	+0.26%	-8.80%	-9.36%	13.02B
Average	-0.90%	-3.58%	+14.07%	+44.42%	39.08B
Weighted average by Cap.	-0.31%	-3.96%	+26.94%	+41.61%

	2024	2025
Net sales	53.79M 61.55M 49.72M 45.94M 86.51M 5.91B 88.07M 593M 233M 2.89B 231M 226M 9.97B	55.32M 63.3M 51.14M 47.24M 88.97M 6.08B 90.58M 610M 239M 2.98B 238M 233M 10.25B
Net income	5.28M 6.05M 4.88M 4.51M 8.5M 581M 8.65M 58.24M 22.85M 284M 22.71M 22.21M 979M	5.33M 6.1M 4.93M 4.56M 8.58M 586M 8.73M 58.81M 23.07M 287M 22.93M 22.42M 989M
Net Debt	-20.11M -23.01M -18.59M -17.17M -32.34M -2.21B -32.93M -222M -86.97M -1.08B -86.43M -84.52M -3.73B	-17.59M -20.13M -16.26M -15.02M -28.29M -1.93B -28.8M -194M -76.08M -947M -75.6M -73.93M -3.26B